期刊文献+

心力衰竭大鼠不同时期尾加压素Ⅱ、内皮素-1和肾上腺髓质素水平变化及益气温阳活血方对其影响的研究 被引量:4

Effects of decoction of yiqiwenyanghuoxue on UII,ET-1,ADM in the rats with early heart failure
暂未订购
导出
摘要 目的探讨中药复方益气温阳活血方对早期心力衰竭大鼠血浆尾加压素Ⅱ(UII)、内皮素-1(ET-1)和肾上腺髓质素(ADM)的变化。方法以阿霉素尾静脉注射造模;超声检测评价其心功能、应用放射免疫法检测血浆UⅡ、ET-1、ADM水平在益气温阳活血方治疗前后的变化。结果随着心衰的加重、心室重构形成,模型大鼠血浆ET-1、ADM水平则进性升高,而UⅡ水平进行性降低,益气温阳活血方在心力衰竭的早期即可降低ET-1、ADM水平及升高UⅡ水平。结论UⅡ、ET-1、ADM可作为早期心衰预警标志物;益气温阳活血方通过影响UⅡ、ET-1、ADM的水平,防止心室重塑,改善心脏功能。 Objective To investigate the effects of decoction of yiqiwenyanghuoxue on UII,ET-1,ADM in the rats with early heart failure.Methods The model rats with chronic heart failure(CHF) were injected with Adriamycin and and treated by decoction of yiqiwenyanghuoxue,then UII,ET-1,ADM levels were detected by radio-immunity.Results Compared to the control group,ET-1,ADM levels were significant-ly higher,but UII levels were significantly lower in CHF groups,and those bing higher or lower when heart failure bing aggravating and myocardial remodel-ing.But those can be attenuated by decoction of yiqiwenyanghuoxue.Conclusion UII,ET-1,ADM can be the predictors in early heart failure.Decoction of yiqiwenyanghuoxue can prevent myocardial remodeling and improve heart function through regulating UII,ET-1,ADM levels.
出处 《贵州医药》 CAS 2012年第1期4-7,共4页 Guizhou Medical Journal
基金 贵州省教育厅自然科学研究项目(黔科教2008028号) 贵州省中医药管理局科技课题(黔中医药发[2009]79号) 贵州省科技计划项目(黔科合SY[2010]3121号) 贵阳市科技计划项目([2010]筑科农合同字第1-社-37号)
关键词 早期心力衰竭 尾加压素Ⅱ 内皮素-1 肾上腺髓质素 益气温阳活血方 Eearly heart failure UII ET-1 ADM Decoction of yiqiwenyang-huoxue
  • 相关文献

参考文献13

二级参考文献85

共引文献71

同被引文献51

  • 1富路,戴颖楠,朱立群,万晓京,曹君娴,韩颖,谢荣盛.慢性心功能衰竭患者血浆尾加压素Ⅱ、内皮素和肾上腺髓质素的变化[J].中国动脉硬化杂志,2007,15(3):201-204. 被引量:9
  • 2邓义军,伍卫,方昶,黄至斌,王景峰.β_3-肾上腺素能受体对心力衰竭大鼠心室肌细胞内静息Ca^(2+)浓度的调控及其转导途径[J].南方医科大学学报,2009,29(8):1635-1637. 被引量:6
  • 3钱永如.小儿慢性心力衰竭治疗进展[J].实用儿科临床杂志,2006,21(18):1202-1204. 被引量:5
  • 4Lompre AM, Hajjar RJ, Harding SE, et al. Ca2+ cyc- ling and new therapeutic approaches for heart failure f-J]. Circulation, 2010,121 (6) : 822-830.
  • 5Ding W, Dong M, Deng J, et al. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling path- way[J]. Am J Physiol Heart Circ Physiol, 2014,307 (5) .. H792-802.
  • 6Lunde IG, Kvaly H, Austb B, et al. Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes [J]. J Appl Physiol,2011, 111(5) : 1278-1289.
  • 7Vaudry H,Leprince J,Chatenet D,et al.International Union of Basic and Clinical Pharmacology.XCⅡ.UrotensinⅡ,urotensinⅡ-related peptide,and their receptor:from structure to function[J].Pharmacol Rev,2015,67(1):214-58.
  • 8Suzan T,Hakan K,Mehmet A E,Elif O,et al.Urotensin-Ⅱlevel and its association with oxidative stress in early diabetic nephropathy[J].J Diabetes Complications,2015,29(1):115-119.
  • 9Julia Beilfuss,Vivian Berg,Monica Sneve,Rolf Jorde,Elena Kamycheva.Effects of a 1-year supplementation with cholecalciferol on interleukin-6,tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects[J].Cytokine,2012,60(3):870-874.
  • 10Pedersen BK,Steensberg A,Schjerling P.Muscle-derived interleukin-6:possible biological effects[J].J Physiol,2001,15:329-337.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部